PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,655 stories, page 321 of 645

Advanced search
🇺🇸CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutionsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

tradingview.comOriginal source
🌍Industryir.talphera.comTier 1 · Company source

Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

TalpheraOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Patients with motor neurone disease set for fast-tracked care

Health and Social Care Secretary announces faster access to care and support for motor neurone disea...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amgen Details Phase 3 Sleep Apnea Studies for Investigational Drug MariTide

Sleep ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cleveland startup pitches federal biotech commission on regenerative medicine hub

The Business JournalsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Moderna launches early trial of Ebola mRNA vaccine

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA suspends licenses of 5 food outlets in Pune div

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) After Its Q2 Beat Is The Valuation Case Still Intact

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Security: A New National Defense Priority

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Source Denies AstraZeneca-Bristol Myers Merger Talks | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’

fiercebiotech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

4DMT reports new phase 2b gene therapy data for wet AMD

Glance by Eyes On EyecareOriginal source
🇺🇸Industrytechcyte.comTier 1 · Company source

Cytolab moves its cervical cytology screening to Techcyte SureView®

TechcyteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Government did not conduct impact assessment for community pharmacy prescribing

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sellas Life Sciences faces earnings test as trial nears end

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

COMPASS Pathways Q2 2026 Loss Widens 358.5% Beyond Estimates

AlphaStreetOriginal source
🇺🇰Regulatoryabpi.org.ukTier 1 · Regulatory source

ABPI response to the Budget

ABPI UKOriginal source
🇺🇰Regulatoryabpi.org.ukTier 1 · Regulatory source

UK must get ready for new cell and gene therapies, says ABPI

ABPI UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra becomes 2nd state to ban analogue cheese; violators face up to six months' jail, Rs 1 lakh fine

ANI NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Psychedelic Drug Development Takes Center Stage – Do You Have What it Takes to Bring a Psychedelic Drug to Market?

Spencer FaneOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA’s 2026 Draft Guidance on Nonclinical Safety for Antibody Drug Conjugates

BioPharm InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Guidance, Clinical Pipelines, and the Emerging Deal Landscape of Psychedelic Therapeutics

JD SupraOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech company expanding to Gramercy Park despite industry headwinds

Crain's New York BusinessOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Belgian company selects SA for US headquarters

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

America’s Next Biotech Challenge

RealClearHealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Shionogi Advances Phase 3 Secutrelvir Trial, Eyeing New COVID-19 Market Upside

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Attovia Therapeutics Climbs 24% After $289 Million IPO

Bloomberg.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This Is Nvidia CEO Jensen Huang's Favorite Biotech Stock -- and You've Probably Never Heard of It

The Motley FoolOriginal source
🌍Mediaseqens.comTier 2 · Direct publisher

SEQENS has announced it has reached an agreement in principle on a comprehensive financial restructuring

SeqensOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Attovia adds to biotech IPO momentum with $289M offering

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Scottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Capra Biosciences receives additional funding for domestic pharmaceutical API biomanufacturing

chemengonline.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Commodification of Legal Healing Psychedelics

Heady NJOriginal source
🇩🇪Researchfraunhofer.deTier 2 · Direct publisher

Marc Eichhorn Joins Fraunhofer IOSB’s Institute Management Team

Fraunhofer Life SciencesOriginal source
🌍Researchindicalab.comTier 2 · Direct publisher

Open Science Does Not Require Open Source: The Role of Open Pathology in Research

Indica LabsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Lilly climbs, Novo falls as obesity drug battle intensifies

BioPharma DiveOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Child death overview panels: contacts

Contact details of the people in child death overview panels (CDOPs) who are responsible for receivi...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Seizes ₹55 Crore Unsafe Food in Crackdown

WhalesbookOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Drone Delivery Is Moving Closer to Pharma's Last Mile

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Approach online weight-loss drug offers with skepticism

Lake Okeechobee NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Medera Partners with IQVIA to Accelerate Cardiac Gene Therapies and Human-Based Drug Discovery Platforms

citybizOriginal source
🇯🇵Researchriken.jpTier 2 · Direct publisher

FY2027 CBS Co-Creation of Knowledge Project—Co-Creation Laboratory

RIKENOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

Scientists unveil more than 600 new tissue models of human cancer

MIT Biology NewsOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Medicine supply management

An overview of the systems and processes DHSC and NHS England use for responding to medicine shortag...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Ensuring the efficient supply and distribution of medicines to patients

Guidance on the roles and responsibilities of marketing authorisation holders, wholesalers and procu...

UK Department of Health and Social CareOriginal source
🌍Industryzevra.comTier 1 · Company source

Long-term real-world safety and effectiveness of arimoclomol in individuals with NPC: Outcomes from the US early access program over a 4-year period

Zevra TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA continues Enforcement Drive against Food Safety Violations

KNS NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical earnings ahead after ADHD acquisition By Investing.com

Investing.com NigeriaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Kenco's AI Rollout Signals for 3PL

Pharmaceutical CommerceOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Innovative Nucleic Acids Technologies for Analysis, Detection and Treatment

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Advancing Equity, Diversity and Inclusion in Clinical Trials

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Pan-Africa network for genomic surveillance of poverty related diseases and emerging pathogens

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: EuroPean Training NetwoRks to TArget DAMPs and NETs: novel apprOaches in pRecision SepsIs pAtieNt care

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: European Cohorts of Patients and Schools to Advance Response to Epidemics

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Intelligent Lung Support for Mechanically Ventilated Patients in the Intensive Care Unit

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors

CORDISOriginal source
🌍Researchuab.eduTier 2 · Direct publisher

Getting mealtime back on track: How to ease the back-to-school transition for parents and children

University of Alabama at BirminghamOriginal source